Lung Cancer Screening. The Pulmonologist’s Role in Improving Personalized Diagnosis and Treatment of NSCLC.

Slides:

Advertisements

Similar presentations

Melanoma Focus Meeting 2012 Mutation Testing: Why, When, Which and How?

Advertisements

Chapter 28 Lung Cancer. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Objectives  Describe the epidemiology of.

Stem Cells In Clinical Practice: STELLA Experience Manolo D’Arcangelo Department of Oncology Ospedale Civile di Livorno.

ERS Conference Sudhir Rao. Interventional Pulmonary Procedures- What was New? EBUS-TBNA & EUS-FNA- C Dooms (Leuven, Belgium)- No ROSE and perform at least.

Routine PSA: Evaluating the Evidence Sheldon Greenfield, MD Health Policy Research Institute University of California, Irvine October 23, 2012.

Slides last updated: March There are two main types of lung cancer 1 1.Howlader N, Noone AM, Krapcho M, et al. (eds). SEER Cancer Statistics Review,

REDUCED LUNG-CANCER MORTALITY WITH LOW-DOSE COMPUTED TOMOGRAPHIC SCREENING The National Lung Screening Trial Research Team N Engl J Med 2011;365:

Available specimen depend on the stage and type of cancer Inoperable NSCLC (50%): here we have specimen from bronchoscopy (bronchial bx, brush cytology,

Genesis Oncology Trust Palliative Care Lecture Series Dr Helen Winter 3 rd July

Where Are We on the Path to Elimination of Chronic Hepatitis C?

Sensitivity and Diagnostic Accuracy of Different Sampling Modalities with Electromagnetic Navigational Bronchoscopy & Effect of Radial EBUS on Yield Deepankar.

Approximately 85% of lung cancers are classified as non-small cell lung cancer (NSCLC); of these, adenocarcinoma accounts for 50% of cases, and squamous.

Patient Case 1 Patient Case 1: PET/CT Scan.

Unità Clinica di Diagnostica Istopatologica e Molecolare

NOACs for Cancer-Associated Thrombosis:

Strategies for the Management of EGFR TKI Resistance in Advanced NSCLC

Clinical Considerations in the Management of EGFR-Mutated Advanced NSCLC.

Advanced NSCLC Without Actionable Mutations

Cardiogenic Shock.

The Clinical Enigma of Cardiogenic Shock

Fundamental Concepts in the Diagnosis of Advanced NSCLC

Assessing the Impact: New Data in T790+ NSCLC

Progression After Cancer Immunotherapy in Advanced NSCLC

Tissue Acquisition and Reflex Testing How do we Prioritize?

New Standards of Care in ALK-Translocated Advanced NSCLC

Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.

The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer

Learning Objectives. A Multidisciplinary Approach in Advanced NSCLC in the Era of Immuno-Oncology.

Introduction. For Pulmonologists by Pulmonologists: Diagnosis of NSCLC in an Age of Biomarkers.

T790M Mutation-Positive NSCLC: A Multidisciplinary Case Conference

LUNG CANCER SCREENING & SMOKING CESSATION

Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.

Endobronchial ultrasonography (EBUS)—Its role in staging of non–small cell lung cancer and who should do it? Rafael S. Andrade, MD, David D. Odell, MD,

More Than Meets the Eye.

Case Collection in RA: Highlights of an Interactive Workshop

Tissue acquisition and reflex testing. How do we prioritize?

Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.

Transbronchial Biopsy Needle Rinse Solution Used for Comprehensive Biomarker Testing in Patients with Lung Cancer Yuichi Sakairi, MD, PhD, Kenichi Sato,

Clinicopathologic Analysis of ROS1-Rearranged Non–Small-Cell Lung Cancer and Proposal of a Diagnostic Algorithm Heounjeong Go, MD, PhD, Dong-Wan Kim,

Moving Care Forward in Advanced NSCLC

Immune Checkpoint Inhibitors in Lung Cancer

The Road to Quality Improvement in HER2-Positive Breast Cancer

How I Do It—Optimal Methodology for Multidirectional Analysis of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples Takahiro Nakajima,

Understanding the Updated Guidelines for ALK Testing in NSCLC

Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.

Comparison of the Yield of Different Diagnostic Procedures for Cellular Differentiation and Genetic Profiling of Non–Small-Cell Lung Cancer Amr S. Albanna,

Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC

The Nuances of Staging Lung cancer Gerard A

Biomarker Testing: Harnessing All Sides of the Tumor Microenvironment

Patient-Centered Management in Advanced Non-Small Cell Lung Cancer

All for One: Multidisciplinary Management in EGFR-Mutated NSCLC

Practical Guidance on the Management of Pan-Negative NSCLC

Practical Strategies to Guideline-Recommended Biomarker Testing in NSCLC.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.

Multidisciplinary Management in Non-Small Cell Lung Cancer (NSCLC)

Optimizing Characterization of NSCLC Through Specialty Collaboration

THE CONTINUUM OF CARE IN mCRC: OPTIMIZING USE OF EGFR ANTIBODIES

Volume 155, Issue 1, Pages (January 2019)

Quality Improvement and Molecular Profiling in Advanced Non-Small Cell Lung Cancer.

Educational Objectives

Fundamentals of Flexible Bronchoscopy Conventional Transbronchial Needle Aspiration RESULTS AND COMPLICATIONS

Third-Generation EGFR TKIs

The Nurse View: Spotlight on EGFR-Mutated NSCLC

Finding the Right Sequence in Patients With EGFR-Mutated NSCLC

Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer.

Next-Generation Sequencing and ctDNA

Lung Cancer screening. The NELSON trial.

Updates in Best Practices in Non-Small Cell Lung Cancer

ENTPD5 expression correlates with EGFR and activated AKT levels in human NSCLC. A, percentages of PTEN-low lung adenocarcinoma cases with at least one.

Presentation transcript:

The Pulmonologist’s Role in Improving Personalized Diagnosis and Treatment of NSCLC

Lung Cancer Screening

NLST Study Design

NLST Lung Cancer Mortality

Lung Cancer Screening 2013 Recommendations From the USPSTF

Lung Cancer Screening Issues Related to Effective Implementation

Reclassifying Lung Adenocarcinoma Recommendations from IASLC/ATS/ERS

Resection Specimens IASLC/ATS/ERS Recommendations for Classification of Adenocarcinoma

Small Biopsies and Cytologic Specimens Highlights From IASLC/ATS/ERS Recommendations

Biopsy Procedures and Issues in Advanced NSCLC

Sampling in Suspected Advanced NSCLC

Transthoracic Core Needle Biopsy in BATTLE Lung Trial

Cytologic Specimens for Histologic Subtyping and Genotyping EBUS-TBNA

Biopsy Issues Best Practices in the Setting of Suspected Advanced NSCLC

Limitations of NSCLC-NOS

Effect of NSCLC-NOS on Treatment Selection in Advanced NSCLC

Effect of NSCLC-NOS on Treatment Selection in Advanced NSCLC (cont)

Molecular Testing Guidelines CAP/ASIP/AMP/IASLC

Molecular Testing Guidelines Who, When, and What of EGFR and ALK Testing

ROSE

ROSE Suggested Algorithm for Processing EBUS-TBNA Specimens

Abbreviations

References

References (cont)

References (cont)

References (cont)